An Act relative to costs for treatment and management of diabetes
This bill limits the out-of-pocket costs that health insurance plans in Massachusetts must charge for diabetes-related medications. It directly affects people with diabetes and the insurance companies that cover their treatment. Under the new rules, plans cannot charge more than $25 for a 30-day supply of insulin, $50 for oral diabetes medications, or $100 for other covered diabetes items. These cost caps apply across various types of health insurance, including private plans, Medicaid, and other state-regulated coverage.
Bill status
passed
3 of 4 stages cleared
Introduction
Feb 2023
Committee Review
Feb 2024
Senate Passage
Feb 2023
Governor
Introduced Feb 16, 2023
Last action May 9, 2024
Floor votes
How they voted
This bill passed the Senate. No roll call record of that vote is available.
Full legislative history
Actions timeline
Total actions
5
Key actions
1
Committee
2
Feb 22, 2024
Committee
Reported favorably by committee and referred to the committee on Health Care Financing
lower
Feb 16, 2023
Upper · Passed
Senate concurred
upper
Feb 16, 2023
Committee
Referred to the committee on Financial Services
lower
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Pete Capano
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about H 963
Scope: MA
Hi! I can help you understand H 963. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline